WCM
UTHR icon

Wedge Capital Management’s United Therapeutics UTHR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$27.5M Sell
95,844
-11,432
-11% -$3.28M 0.49% 85
2025
Q1
$33.1M Buy
107,276
+27,829
+35% +$8.58M 0.64% 69
2024
Q4
$28M Sell
79,447
-10,132
-11% -$3.57M 0.5% 77
2024
Q3
$32.1M Sell
89,579
-37,230
-29% -$13.3M 0.55% 71
2024
Q2
$40.4M Sell
126,809
-43,740
-26% -$13.9M 0.72% 53
2024
Q1
$39.2M Buy
+170,549
New +$39.2M 0.63% 68
2023
Q1
Sell
-143,163
Closed -$39.8M 450
2022
Q4
$39.8M Sell
143,163
-22,343
-13% -$6.21M 0.64% 32
2022
Q3
$34.7M Buy
165,506
+5,478
+3% +$1.15M 0.59% 60
2022
Q2
$37.7M Sell
160,028
-17,635
-10% -$4.16M 0.6% 47
2022
Q1
$31.9M Buy
177,663
+15,564
+10% +$2.79M 0.43% 106
2021
Q4
$35M Buy
162,099
+3,864
+2% +$835K 0.43% 89
2021
Q3
$29.2M Sell
158,235
-25,758
-14% -$4.75M 0.38% 110
2021
Q2
$33M Sell
183,993
-5,633
-3% -$1.01M 0.4% 72
2021
Q1
$31.7M Sell
189,626
-9,490
-5% -$1.59M 0.38% 111
2020
Q4
$30.2M Sell
199,116
-56,611
-22% -$8.59M 0.35% 83
2020
Q3
$25.8M Sell
255,727
-31,128
-11% -$3.14M 0.35% 114
2020
Q2
$34.7M Buy
+286,855
New +$34.7M 0.48% 66
2019
Q2
Sell
-335,155
Closed -$39.3M 638
2019
Q1
$39.3M Buy
335,155
+39,737
+13% +$4.66M 0.45% 77
2018
Q4
$32.2M Buy
295,418
+25,075
+9% +$2.73M 0.4% 88
2018
Q3
$34.6M Sell
270,343
-2,990
-1% -$382K 0.33% 96
2018
Q2
$30.9M Sell
273,333
-47,559
-15% -$5.38M 0.3% 94
2018
Q1
$36.1M Sell
320,892
-3,739
-1% -$420K 0.35% 81
2017
Q4
$48M Buy
324,631
+313,143
+2,726% +$46.3M 0.43% 59
2017
Q3
$1.35M Buy
11,488
+2,059
+22% +$241K 0.01% 322
2017
Q2
$1.22M Buy
9,429
+1,362
+17% +$177K 0.01% 312
2017
Q1
$1.09M Buy
8,067
+213
+3% +$28.8K 0.01% 319
2016
Q4
$1.13M Sell
7,854
-401
-5% -$57.5K 0.01% 320
2016
Q3
$975K Sell
8,255
-1,235
-13% -$146K 0.01% 329
2016
Q2
$1.01M Buy
9,490
+1,774
+23% +$188K 0.01% 316
2016
Q1
$860K Buy
+7,716
New +$860K 0.01% 336
2014
Q3
Sell
-7,125
Closed -$630K 599
2014
Q2
$630K Buy
7,125
+3,700
+108% +$327K 0.01% 405
2014
Q1
$322K Sell
3,425
-150
-4% -$14.1K ﹤0.01% 427
2013
Q4
$404K Buy
+3,575
New +$404K ﹤0.01% 384